Broadcom Inc. (AVGO) vs Eli Lilly and Company (LLY)
See how Broadcom Inc. and Eli Lilly and Company differ across market data and performance, so you can decide which asset best fits your strategy.
$370.83
NasdaqGS
Broadcom Inc. is one of the world’s largest semiconductor companies and has also built a significant presence in infrastructure software. Its chip business is mainly focused on computing and networking, with custom AI accelerators now representing the majority of operations. Broadcom primarily operates as a fabless chip designer, though it retains some in-house manufacturing, including its leading film bulk acoustic resonator filters used in Apple iPhones. On the software side, the company provides virtualization, infrastructure, and security solutions to large enterprises, financial institutions, and government customers. Broadcom has grown through consolidation, combining businesses from legacy Broadcom and Avago Technologies in semiconductors, along with VMware, Brocade, CA Technologies, and Symantec in software.
Eli Lilly & Co. is a pharmaceutical company focused on neuroscience, cardiometabolic disease, oncology, and immunology. Its leading products include Verzenio and Jaypirca in cancer treatment; Mounjaro, Zepbound, Foundayo, Jardiance, Trulicity, Humalog, and Humulin in cardiometabolic care; and Taltz and Olumiant in immunology.